SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Makers Laboratories - Quaterly Results

09 Feb 2022 Evaluate
The sales surged to Rs. 135.09 millions, up 28.91% for the December 2021 quarter as against Rs. 104.79 millions during the corresponding quarter previous year.The Total Profit for the quarter ended December 2021 of Rs. 6.67 millions grew from Rs.-18.27 millions Operating profit Margin for the quarter ended December 2021 improved to 14.64% as compared to -4.32% of corresponding quarter ended December 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 135.09 104.79 28.91 433.82 332.85 30.33 444.11 513.97 -13.59
Other Income 0.41 0.46 -10.87 7.65 3.66 109.02 4.14 2.26 83.19
PBIDT 14.64 -4.32 -438.89 48.43 28.75 68.45 37.11 29.40 26.22
Interest 3.89 3.99 -2.51 12.80 11.67 9.68 15.89 7.03 126.03
PBDT 10.75 -8.31 -229.36 35.63 17.08 108.61 21.22 22.37 -5.14
Depreciation 4.75 10.82 -56.10 14.36 31.05 -53.75 41.96 19.88 111.07
PBT 6.00 -19.13 -131.36 21.27 -13.97 -252.25 -20.74 2.49 -932.93
TAX -0.67 -0.86 -22.09 3.52 -5.27 -166.79 -4.57 3.73 -222.52
Deferred Tax 0.78 0.00 0.00 2.67 -3.77 -170.82 -2.90 3.35 -186.57
PAT 6.67 -18.27 -136.51 17.75 -8.70 -304.02 -16.17 -1.24 1204.03
Equity 49.17 49.17 0.00 49.17 49.17 0.00 49.17 49.17 0.00
PBIDTM(%) 10.84 -4.12 -362.88 11.16 8.64 29.25 8.36 5.72 46.08

Makers Laboratories Share Price

160.00 -4.15 (-2.53%)
16-Apr-2026 14:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1683.65
Dr. Reddys Lab 1224.20
Cipla 1228.75
Zydus Lifesciences 937.15
Lupin 2313.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×